Evidence map›Paper›PMID 38519096›Full record

Observational studyBMJ global health2024

Reduction of malaria case incidence following the introduction of clothianidin-based indoor residual spraying in previously unsprayed districts: an observational analysis using health facility register data from Côte d'Ivoire, 2018-2022.

Emily R Hilton, Ndombour Gning-Cisse, Auguste Assi, Mathieu Eyakou, John Koffi, Barthelemy Gnakou, Bernard Kouassi, Cecilia Flatley, Joseph Chabi, Constant Gbalegba and 14 more

Abstract readObservational Study
In one paragraph

Observational study in BMJ global health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Emily R HiltonPMI VectorLink Project, PATH, Seattle, Washington, USA ehilton@path.org.ORCID http://orcid.org/0000-0001-9319-5203
Ndombour Gning-CissePMI VectorLink Project, Abt Associates, Abidjan, Côte d'Ivoire.
Auguste AssiPMI VectorLink Project, Abt Associates, Abidjan, Côte d'Ivoire.
Mathieu EyakouPMI VectorLink Project, Abt Associates, Abidjan, Côte d'Ivoire.
John KoffiPMI VectorLink Project, Abt Associates, Abidjan, Côte d'Ivoire.
Barthelemy GnakouPMI VectorLink Project, Abt Associates, Abidjan, Côte d'Ivoire.
Bernard KouassiPMI VectorLink Project, Abt Associates, Abidjan, Côte d'Ivoire.
Cecilia FlatleyPMI VectorLink Project, Abt Associates, Rockville, Maryland, USA.
Joseph ChabiPMI VectorLink Project, Abt Associates, Rockville, Maryland, USA.
Constant GbalegbaProgramme National de Lutte Contre le Paludisme, Abidjan, Côte d'Ivoire.ORCID http://orcid.org/0000-0003-3217-3398
Serge Alex AimainProgramme National de Lutte Contre le Paludisme, Abidjan, Côte d'Ivoire.
Colette Yah KokrassetProgramme National de Lutte Contre le Paludisme, Abidjan, Côte d'Ivoire.
Mea Antoine TanohProgramme National de Lutte Contre le Paludisme, Abidjan, Côte d'Ivoire.
Sylvain N'GottaProgramme National de Lutte Contre le Paludisme, Abidjan, Côte d'Ivoire.
Octavie YaoProgramme National de Lutte Contre le Paludisme, Abidjan, Côte d'Ivoire.
Hughes Egou AssiDirection de l'Informatique et de l'Information Sanitaire, Abidjan, Côte d'Ivoire.
Philomène KonanDirection de l'Informatique et de l'Information Sanitaire, Abidjan, Côte d'Ivoire.
Kelly DavisPMI VectorLink Project, PATH, Washington, District of Columbia, USA.
Edi ConstantCentre Suisse de Recherches Scientifiques en Côte d'Ivoire, Abidjan, Côte d'Ivoire.
Allison BelemvireUS President's Malaria Initiative, US Agency for International Development, Washington, District of Columbia, USA.
Patricia Yepassis-ZembrouU.S. President's Malaria Initiative, Centers for Disease Control and Prevention, Abidjan, Côte d'Ivoire.
Pascal ZinzindohoueU.S. President's Malaria Initiative, U.S. Agency for International Development, Abidjan, Côte d'Ivoire.
Blaise KouadioU.S. President's Malaria Initiative, U.S. Agency for International Development, Abidjan, Côte d'Ivoire.
Sarah BurnettPMI VectorLink Project, PATH, Washington, District of Columbia, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIndoor residual spraying (IRS) using neonicotinoid-based insecticides (clothianidin and combined clothianidin with deltamethrin) was deployed in two previously unsprayed districts of Côte d'Ivoire in 2020 and 2021 to complement standard pyrethroid insecticide-treated nets. This retrospective observational study uses health facility register data to assess the impact of IRS on clinically reported malaria case incidence.

methodsHealth facility data were abstracted from consultation registers for the period September 2018 to April 2022 in two IRS districts and two control districts that did not receive IRS. Malaria cases reported by community health workers (CHWs) were obtained from district reports and District Health Information Systems 2. Facilities missing complete data were excluded. Controlled interrupted time series models were used to estimate the effect of IRS on monthly all-ages population-adjusted confirmed malaria cases and cases averted by IRS. Models controlled for transmission season, precipitation, vegetation, temperature, proportion of cases reported by CHWs, proportion of tested out of suspected cases and non-malaria outpatient visits.

resultsAn estimated 10 988 (95% CI 5694 to 18 188) malaria cases were averted in IRS districts the year following the 2020 IRS campaign, representing a 15.9% reduction compared with if IRS had not been deployed. Case incidence in IRS districts dropped by 27.7% (incidence rate ratio (IRR) 0.723, 95% CI 0.592 to 0.885) the month after the campaign. In the 8 months after the 2021 campaign, 14 170 (95% CI 13 133 to 15 025) estimated cases were averted, a 24.7% reduction, and incidence in IRS districts dropped by 37.9% (IRR 0.621, 95% CI 0.462 to 0.835) immediately after IRS. Case incidence in control districts did not change following IRS either year (p>0.05) and the difference in incidence level change between IRS and control districts was significant both years (p<0.05).

conclusionDeployment of clothianidin-based IRS was associated with a reduction in malaria case rates in two districts of Côte d'Ivoire following IRS deployment in 2020 and 2021.

Indexed as

GuanidinesInsecticidesMalariaThiazolesCote d'IvoireHealth FacilitiesHumansIncidenceMosquito ControlNeonicotinoidsclothianidinGuanidinesInsecticidesNeonicotinoidsThiazolesepidemiologymalariapublic health

Identifiers

PMID38519096
PMCPMC10961507

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.